How Much Weight Can You Lose on Mounjaro in 3 Months?

What clinical trials actually recorded at 12 weeks

The SURMOUNT-1 trial is the most rigorous evidence we have. Over 72 weeks, tirzepatide (the active medicine in Mounjaro) produced average weight reductions of around 20–21% at the highest dose — figures that NICE's appraisal of tirzepatide (TA1026) draws on in its recommendation. The 12-week point sits inside the dose-escalation period. Most people spend the first four weeks on 2.5mg (a dose whose job is to settle the system, not to deliver full effect) then move to 5mg. At that stage the medicine is doing real work, but the body hasn't yet had months of reduced appetite to build on.

Interim figures from the trial suggest roughly 6–10% of starting body weight is a reasonable expectation by week 12, though the range is wide. Someone starting at 100kg might see 6–10kg of change, and our page on how much weight you can lose on 2.5mg Mounjaro looks specifically at what the opening dose contributes to that early picture. Someone with a different metabolic picture, activity level or starting dose history may see more or less. That spread is why a prescriber reviews your progress, not a fixed chart. If you want a closer look at what the data show across the full treatment arc, our page on how much weight you can lose on Mounjaro overall covers the 72-week picture in full.

Why three months is still early (and why that matters for pricing

A question our prescribers hear most weeks is some version of: "I've only been on it three months) is it working?" The honest answer is that three months is genuine progress, but it is not the finish line. Tirzepatide's mechanism (activating both GIP and GLP-1 receptors to reduce appetite and slow gastric emptying) compounds over time, and if you are curious about what a single month of tirzepatide can realistically deliver, our page on how much you can lose on tirzepatide in a month breaks that down in detail. Weight loss at month six is typically greater than at month three, and month twelve greater still.

This is relevant to cost because some providers price by the month and market a low entry figure. Three months of treatment at a starter dose is cheaper than three months at a maintenance dose, so a headline monthly price quoted at 2.5mg looks attractive, but it does not reflect what sustained treatment costs. UK Mounjaro pricing has also shifted significantly: Eli Lilly raised its UK list price from 1 September 2025, and reported private market prices since then range roughly £149–£375 per month by dose and provider. Any figure you see advertised is worth reading carefully to understand which dose it covers.

For context on the 5mg phase specifically, what to expect at the 5mg dose sets out realistic expectations for that step of treatment.

What a transparent price for three months of treatment should include

Headline prices for weight-loss injections often exclude several things: the prescriber consultation, the prescription fee, delivery, and any clinical support between orders. Add those up across three months and a cheaper-looking per-pen price can close the gap quickly. It is also worth asking whether a repeat order triggers a fresh clinical review or just an automatic re-send, for a prescription medicine, the former is the standard that keeps you safe.

At nume, one price covers the consultation, the prescription, next-working-day DPD delivery and aftercare access seven days a week. We are not the cheapest option in the market, that is a deliberate choice, not an oversight. The current treatment pricing is on our treatment page, and it is the same price whether you order once or twenty times. No subscriptions. No codes that shave a few pounds off a medicine that should only reach you through a verified supply chain.

You can verify any online pharmacy (including ours) on the GPhC register (premises number 9012878). It takes thirty seconds and it is the single most useful thing you can do before placing any order for a prescription-only medicine online.

The metric that matters more than price

For a prescription medicine, the cheapest listing answers the wrong question. The MHRA has warned publicly about fake weight-loss pens sold through social media and unverified websites, pens that have contained insulin rather than tirzepatide, and which have caused hospitalisations. Counterfeit tirzepatide pens have been seized in the UK, including from an illicit manufacturing site. The risk is real, and a low price from an unverifiable seller is one of the clearest red flags.

The right questions for three months of Mounjaro treatment are: is this a licensed medicine from a pharmacy I can verify? Is a real prescriber reviewing my health before each supply? And is the clinical supervision structured to catch problems early? Those are the factors that determine whether three months of treatment is productive and safe, not whether the per-pen price is £15 lower than the next result on the page. To understand whether you are likely to be eligible, our page on the weight criteria for Mounjaro sets out the clinical thresholds clearly. When you are ready, check your eligibility with our prescribers, the consultation is free, and reviewed the same day.